Trifecta Capital Advisors, LLC Boston Scientific Corp Transaction History
Trifecta Capital Advisors, LLC
- $452 Billion
- Q2 2024
A detailed history of Trifecta Capital Advisors, LLC transactions in Boston Scientific Corp stock. As of the latest transaction made, Trifecta Capital Advisors, LLC holds 50 shares of BSX stock, worth $4,196. This represents 0.0% of its overall portfolio holdings.
Number of Shares
50
Previous 50
-0.0%
Holding current value
$4,196
Previous $3.43 Million
12.44%
% of portfolio
0.0%
Previous 0.0%
Shares
1 transactions
Others Institutions Holding BSX
# of Institutions
1,448Shares Held
1.21BCall Options Held
8.14MPut Options Held
8.3M-
Vanguard Group Inc Valley Forge, PA130MShares$10.9 Billion0.2% of portfolio
-
Black Rock Inc. New York, NY126MShares$10.6 Billion0.22% of portfolio
-
State Street Corp Boston, MA61.5MShares$5.16 Billion0.21% of portfolio
-
Primecap Management CO Pasadena, CA38MShares$3.19 Billion2.15% of portfolio
-
Wellington Management Group LLP Boston, MA32.1MShares$2.69 Billion0.45% of portfolio
About BOSTON SCIENTIFIC CORP
- Ticker BSX
- Exchange NYSE
- Sector Healthcare
- Industry Medical Devices
- Shares Outstandng 1,431,609,984
- Market Cap $120B
- Description
- Boston Scientific Corporation develops, manufactures, and markets medical devices for use in various interventional medical specialties worldwide. It operates through three segments: MedSurg, Rhythm and Neuro, and Cardiovascular. The company offers devices to diagnose and treat gastrointestinal and pulmonary conditions; devices to treat various ...